Hypoxia dose painting in prostate and cervix cancer

References

• Höckel M, Knoop C, Schlenger K, Vorndran B, Baussmann E, Mitze M, et al. Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 1993;26:45–50.
   PubMed Web of Science ®Google Scholar
• Fyles AW, Milosevic M, Wong R, Kavanagh MC, Pintilie M, Sun A, et al. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol 1998;48:149–56.
   PubMed Web of Science ®Google Scholar
• Nordsmark M, Loncaster J, Aquino-Parsons C, Chou SC, Ladekarl M, Havsteen H, et al. Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas. Radiother Oncol 2003;67:35–4.
   PubMed Web of Science ®Google Scholar
• Milosevic M, Warde P, Menard C, Chung P, Toi A, Ishkanian A, et al. Tumour hypoxia predicts biochemical failure following radiotherapy for clinically localised prostate cancer. Clin Can Res 2014;18:2108–14.
   Web of Science ®Google Scholar
• Nordsmark M, Loncaster J, Aquino-Parsons C, Chou SC, Gebski V, West C, et al. The prognostic value of pimonidazole and tumour pO2 in human cervix carcinomas after radiation therapy: A prospective international multi-center study. Radiother Oncol 2006;80:123–31.
   PubMed Web of Science ®Google Scholar
• Fyles AW, Milosevic M, Wong R, Kavanagh MC, Pintilie M, Sun A, et al. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol 1998;48:149–56.
   PubMed Web of Science ®Google Scholar
• Noordhuis MG1, Eijsink JJ, Roossink F, de Graeff P, Pras E, Schuuring E, et al. Prognostic cell biological markers in cervical cancer patients primarily treated with (chemo)radiation: A systematic review. Int J Radiat Oncol Biol Phys 2011;79:325–34.
   PubMed Web of Science ®Google Scholar
• Bristow RG1, Berlin A, Dal Pra A. An arranged marriage for precision medicine: Hypoxia and genomic assays in localized prostate cancer radiotherapy. Br J Radiol 2014;87:20130753.
   PubMed Web of Science ®Google Scholar
• Hammond E, Asselin M-C, Forster D, O’Connor JPB, Senra JM, Williams KJ. The meaning, measurement and modification of hypoxia in the laboratory and the clinic. Clin Oncol (R Coll Radiol) 2014;26:277–88.
   PubMed Web of Science ®Google Scholar
• Gulliksrud K, Ovrebo KM, Mathieson B, Rofstad EK. Differentiation between hypoxic and non-hypoxic experimental tumours by dynamic contrast-enhanced magnetic resonance imaging. Radiother Oncol 2011;98:360–4.
   PubMed Web of Science ®Google Scholar
• Teo QQ, Thng CH, Koh TS, Ng QS. Dynamic contrast-enhanced magnetic resonance imaging: Applications in oncology. Clin Oncol (R Coll Radiol) 2014:26:e9–20.
   PubMed Web of Science ®Google Scholar
• Hoskin PJ, Carnell DM, Taylor NJ, Smith RE, Stirling JJ, Daley FM, et al. Hypoxia in prostate cancer: Correlation of BOLD-MRI with pimonidazole immunohistochemistry-initial observations. Int J Radiat Oncol Biol Phys 2007;68:1065–71.
   PubMed Web of Science ®Google Scholar
• Busk M, Jakobsen S, Horsman MR, Mortensen LS, Iversen AB, Overgaard J, et al. PET imaging of tumor hypoxia using 18F-labeled pimonidazole. Acta Oncol 2013;52:1300–7.
   PubMed Web of Science ®Google Scholar
• Schuetz M, Schmidt M, Potter R, Kommata S, Georg D, Lukic D, et al. Evaluating repetitive 18F-fluoroazamycin-arabinoside (18F-AZA) in the setting on MR-guided adaptive radiotherapy in cervical cancer. Acta Oncol 2010;49: 941–7.
   PubMed Web of Science ®Google Scholar
• Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Futterer JJ, et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: Recommendations from a European consensus meeting. Eur Urol 2011;59:477–94.
   PubMed Web of Science ®Google Scholar
• Futterer J, Briganti A, De Visschere P, Emberton M, Giannarini G, Kirkham A, et al. Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur Urol Epub 2015 Feb 2. pii: S0302–2838(15)00036–6.
   Google Scholar
• Alonzi R, Padhani AR, Maxwell RJ, Taylor NJ, Stirling JJ, Wilson JI, et al. Carbogen breathing increases prostate cancer oxygenation: A translational MRI study in murine xenografts and humans. Br J Cancer 2009;100:644–8.
   PubMed Web of Science ®Google Scholar
• Koyama T, Tamai K, Togashi K. Staging of carcinoma of the uterine cervix and endometrium. Eur Radiol 2007;17: 2009–19.
   PubMed Web of Science ®Google Scholar
• Halle C, Andersen E, Lande M, Aarnes EK, Hasvold G, Holden M, et al. Hypoxia-induced gene expression in chemoresistant cervical cancer revealed by dynamic contrast enhanced MR. Cancer Res 2012;72:5285–95.
   PubMed Web of Science ®Google Scholar
• Lin Z, Mechalakos J, Nehmeh S, Schoder H, Lee N, Humm J, et al. The influence of changes in tumor hypoxia on dose- painting treatment plans based on 18F-FMISO positron emission tomography. Int J Radiat Oncol Biol Phys 2008;70: 1219–28.
   PubMed Web of Science ®Google Scholar
• Dische S, Saunders MI, Sealy R, Werner ID, Verma N, Foy C, et al. Carcinoma of the cervix and the use of hyperbaric oxygen with radiotherapy: A report of a randomised controlled trial. Radiother Oncol 1999;53:93–8.
   PubMed Web of Science ®Google Scholar
• Grigsby PW, Winter K, Wasserman TH, Marcial V, Rotman M, Cooper J, et al. Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80-05. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1999;44:513–7.
   PubMed Web of Science ®Google Scholar
• MRC Working Party. A trial of Ro 03-8799 (pimonidazole) in carcinoma of the uterine cervix: An interim report from the Medical Research Council Working Party on advanced carcinoma of the cervix. Radiother Oncol 1993;26:93–103.
   PubMed Web of Science ®Google Scholar
• Overgaard J. Hypoxia radiosensitisation. Adored and Ignored. J Clin Oncol 2007;25:4066–74.
   PubMed Web of Science ®Google Scholar
• Schütze C, Bergmann R, Brüchner K, Mosch B, Yaromina A, Zips D, et al. Effect of [18F]FMISO stratified dose-escalation on local control in FaDu hSCC in nude mice. Radioth Oncol 2014;113:81–7.
   Web of Science ®Google Scholar
• Rijkhorst EJ, Lakeman A, Nijkamp J, de Bois J, van Herk M, Lebesque JV, et al. Strategies for online organ motion correction for intensity-modulated radiotherapy of prostate cancer: Prostate, rectum, and bladder dose effects. Int J Radiat Oncol Biol Phys 2009;75:1254–60.
   PubMed Web of Science ®Google Scholar
• Jadon R, Pembroke CA, Hanna CL, Palaniappan N, Evans M, Cleves AE, et al. A systematic review of organ motion and image-guided strategies in external beam radiotherapy for cervical cancer. Clin Oncol (R Coll Radiol) 2014;26:185–9.
   PubMed Web of Science ®Google Scholar
• Muren LP, Thwaites DI. The on-going quest for treatment precision and conformality in radiotherapy. Radiother Oncol 2013;109:337–41.
   PubMed Web of Science ®Google Scholar
• Lennernäs B, Castellano E, Nilsson S, Levitt S. Four and five dimensional radiotherapy with reference to prostate cancer – definitions, state of the art and further directions – an overview. Acta Oncol 2011;50:S1, 104–10.
   PubMed Web of Science ®Google Scholar
• Boydev C, Taleb-Ahmed A, Derraz F, Peyrodie L, Thiran JP, Pasquier D. Development of CBCT-based prostate setup correction strategies and impact of rectal distension. Radiat Oncol 2015;10:83.
   PubMedGoogle Scholar
• Ahmad R, Bondar L, Voet P, Mens JW, Quint S, Dhawtal G, et al. A margin-of-the-day online adaptive intensity-modulated radiotherapy strategy for cervical cancer provides superior treatment accuracy compared to clinically recommended margins: a dosimetric evaluation. Acta Oncol 2013;52:1430–6.
   PubMed Web of Science ®Google Scholar
• Henderson DR, Tree AC, van As NJ. Stereotactic body radiotherapy for prostate cancer. Clin Oncol (R Coll Radiol) 2015;27:270–9.
   PubMed Web of Science ®Google Scholar
• Cengiz M, Dogan A, Ozyigit G, Erturk E, Yildiz F, Selek U, et al. Comparison of intracavitary brachytherapy and stereotactic body radiotherapy dose distribution for cervical cancer. Brachytherapy 2012;11:125–9.
   PubMed Web of Science ®Google Scholar
• Hoskin PJ, Colombo A, Henry A, Niehoff P, Paulsen Hellebust T, Siebert FA, et al. GEC/ESTRO recommendations on high dose rate after loading brachytherapy for localised prostate cancer: An update. Radiother Oncol 2013;107:325–32.
   PubMed Web of Science ®Google Scholar
• Dankulchai P, Alonzi R, Lowe GJ, Burnley J, Padhani AR, Hoskin PJ. Optimal source distribution for focal boosts using high dose rate (HDR) brachytherapy alone in prostate cancer. Radiother Oncol 2014;113:121–5.
   PubMed Web of Science ®Google Scholar
• Haie-Meder C, Pötter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005;74:235–45.
   PubMed Web of Science ®Google Scholar
• Ling CC, Humm J, Larson S, Amols H, Fuks Z, Leibel S, et al. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 2000;47:551–60.
   PubMed Web of Science ®Google Scholar
• Morton GC, Hoskin PJ. Brachytherapy: Current status and future strategies – can high dose rate replace low dose rate and external beam radiotherapy? Clin Oncol (R Coll Radiol) 2013;25:474–82.
   PubMed Web of Science ®Google Scholar
• Helou J, D’Alimonte L, Loblaw A, Chung H, Cheung P, Szumacher E, et al. High dose-rate brachytherapy boost for intermediate risk prostate cancer: Long-term outcomes of two different treatment schedules and early biochemical predictors of success. Radiother Oncol 2015;115:84–9.
   PubMed Web of Science ®Google Scholar
• Hoskin P, Rojas A, Ostler P, Hughes R, Alonzi R, Lowe G, et al. High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer: Acute toxicity. Radiother Oncol 2014;110: 268–71.
   PubMed Web of Science ®Google Scholar